Low expression of p27kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma

Shigeto Kawauchi, Yoshinari Goto, Xiu Ping Liu, Tomoko Furuya, Atsunori Oga, Yoshinao Oda, Masazumi Tsuneyoshi, Koichiro Ihara, Kohsuke Sasaki

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

BACKGROUND. Low expression of p27kip1, a dominant cyclin-dependent kinase inhibitor involved in G1-S transition of the cell cycle, recently has been reported to be associated with aggressive tumor growth. It has been shown that active cell proliferation alludes to poor prognosis in patients with synovial sarcoma. However, to the authors knowledge, little is known about the clinicopathologic significance of p27kip1 in synovial sarcoma. METHODS. p27kip1 expression was examined immunohistochemically in 55 cases of primary synovial sarcoma, and the relations between p27kip1 expression and several cell proliferation markers, i.e., mitotic index (MI), Ki-67 labeling index (Ki-67 LI), and clinicopathologic parameters related to poor prognosis, were determined. Univariate and multivariate survival analyses were performed to evaluate the prognostic significance of p27kip1 expression in synovial sarcomas. RESULTS. p27kip1 labeling index (p27kip1 LI) correlated inversely with MI (r = -0.44, P = 0.0007) and Ki-67 LI (r = -0.63, P < 0.0001). Of the clinicopathologic parameters examined, tumor necrosis (P = 0.019) and American Joint Committee on Cancer (AJCC) stage (P = 0.021) correlated significantly with p27kip1 LI. Survival analysis showed that p27kip1 LI was an independent prognostic factor for overall survival in patients with synovial sarcoma (P = 0.0031). CONCLUSIONS. The study results suggested that low expression of p27kip1 may be useful as a marker of poor-prognosis synovial sarcoma.

Original languageEnglish
Pages (from-to)1005-1012
Number of pages8
JournalCancer
Volume91
Issue number5
DOIs
Publication statusPublished - Mar 1 2001

Fingerprint

Synovial Sarcoma
Cyclin-Dependent Kinases
Mitotic Index
Survival Analysis
Cell Proliferation
Neoplasms
Cell Cycle
Necrosis
Multivariate Analysis
Survival
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Low expression of p27kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. / Kawauchi, Shigeto; Goto, Yoshinari; Liu, Xiu Ping; Furuya, Tomoko; Oga, Atsunori; Oda, Yoshinao; Tsuneyoshi, Masazumi; Ihara, Koichiro; Sasaki, Kohsuke.

In: Cancer, Vol. 91, No. 5, 01.03.2001, p. 1005-1012.

Research output: Contribution to journalArticle

Kawauchi, Shigeto ; Goto, Yoshinari ; Liu, Xiu Ping ; Furuya, Tomoko ; Oga, Atsunori ; Oda, Yoshinao ; Tsuneyoshi, Masazumi ; Ihara, Koichiro ; Sasaki, Kohsuke. / Low expression of p27kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma. In: Cancer. 2001 ; Vol. 91, No. 5. pp. 1005-1012.
@article{9f5202d3846e461693a2d92bca51c6ec,
title = "Low expression of p27kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma",
abstract = "BACKGROUND. Low expression of p27kip1, a dominant cyclin-dependent kinase inhibitor involved in G1-S transition of the cell cycle, recently has been reported to be associated with aggressive tumor growth. It has been shown that active cell proliferation alludes to poor prognosis in patients with synovial sarcoma. However, to the authors knowledge, little is known about the clinicopathologic significance of p27kip1 in synovial sarcoma. METHODS. p27kip1 expression was examined immunohistochemically in 55 cases of primary synovial sarcoma, and the relations between p27kip1 expression and several cell proliferation markers, i.e., mitotic index (MI), Ki-67 labeling index (Ki-67 LI), and clinicopathologic parameters related to poor prognosis, were determined. Univariate and multivariate survival analyses were performed to evaluate the prognostic significance of p27kip1 expression in synovial sarcomas. RESULTS. p27kip1 labeling index (p27kip1 LI) correlated inversely with MI (r = -0.44, P = 0.0007) and Ki-67 LI (r = -0.63, P < 0.0001). Of the clinicopathologic parameters examined, tumor necrosis (P = 0.019) and American Joint Committee on Cancer (AJCC) stage (P = 0.021) correlated significantly with p27kip1 LI. Survival analysis showed that p27kip1 LI was an independent prognostic factor for overall survival in patients with synovial sarcoma (P = 0.0031). CONCLUSIONS. The study results suggested that low expression of p27kip1 may be useful as a marker of poor-prognosis synovial sarcoma.",
author = "Shigeto Kawauchi and Yoshinari Goto and Liu, {Xiu Ping} and Tomoko Furuya and Atsunori Oga and Yoshinao Oda and Masazumi Tsuneyoshi and Koichiro Ihara and Kohsuke Sasaki",
year = "2001",
month = "3",
day = "1",
doi = "10.1002/1097-0142(20010301)91:5<1005::AID-CNCR1091>3.0.CO;2-O",
language = "English",
volume = "91",
pages = "1005--1012",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Low expression of p27kip1, a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma

AU - Kawauchi, Shigeto

AU - Goto, Yoshinari

AU - Liu, Xiu Ping

AU - Furuya, Tomoko

AU - Oga, Atsunori

AU - Oda, Yoshinao

AU - Tsuneyoshi, Masazumi

AU - Ihara, Koichiro

AU - Sasaki, Kohsuke

PY - 2001/3/1

Y1 - 2001/3/1

N2 - BACKGROUND. Low expression of p27kip1, a dominant cyclin-dependent kinase inhibitor involved in G1-S transition of the cell cycle, recently has been reported to be associated with aggressive tumor growth. It has been shown that active cell proliferation alludes to poor prognosis in patients with synovial sarcoma. However, to the authors knowledge, little is known about the clinicopathologic significance of p27kip1 in synovial sarcoma. METHODS. p27kip1 expression was examined immunohistochemically in 55 cases of primary synovial sarcoma, and the relations between p27kip1 expression and several cell proliferation markers, i.e., mitotic index (MI), Ki-67 labeling index (Ki-67 LI), and clinicopathologic parameters related to poor prognosis, were determined. Univariate and multivariate survival analyses were performed to evaluate the prognostic significance of p27kip1 expression in synovial sarcomas. RESULTS. p27kip1 labeling index (p27kip1 LI) correlated inversely with MI (r = -0.44, P = 0.0007) and Ki-67 LI (r = -0.63, P < 0.0001). Of the clinicopathologic parameters examined, tumor necrosis (P = 0.019) and American Joint Committee on Cancer (AJCC) stage (P = 0.021) correlated significantly with p27kip1 LI. Survival analysis showed that p27kip1 LI was an independent prognostic factor for overall survival in patients with synovial sarcoma (P = 0.0031). CONCLUSIONS. The study results suggested that low expression of p27kip1 may be useful as a marker of poor-prognosis synovial sarcoma.

AB - BACKGROUND. Low expression of p27kip1, a dominant cyclin-dependent kinase inhibitor involved in G1-S transition of the cell cycle, recently has been reported to be associated with aggressive tumor growth. It has been shown that active cell proliferation alludes to poor prognosis in patients with synovial sarcoma. However, to the authors knowledge, little is known about the clinicopathologic significance of p27kip1 in synovial sarcoma. METHODS. p27kip1 expression was examined immunohistochemically in 55 cases of primary synovial sarcoma, and the relations between p27kip1 expression and several cell proliferation markers, i.e., mitotic index (MI), Ki-67 labeling index (Ki-67 LI), and clinicopathologic parameters related to poor prognosis, were determined. Univariate and multivariate survival analyses were performed to evaluate the prognostic significance of p27kip1 expression in synovial sarcomas. RESULTS. p27kip1 labeling index (p27kip1 LI) correlated inversely with MI (r = -0.44, P = 0.0007) and Ki-67 LI (r = -0.63, P < 0.0001). Of the clinicopathologic parameters examined, tumor necrosis (P = 0.019) and American Joint Committee on Cancer (AJCC) stage (P = 0.021) correlated significantly with p27kip1 LI. Survival analysis showed that p27kip1 LI was an independent prognostic factor for overall survival in patients with synovial sarcoma (P = 0.0031). CONCLUSIONS. The study results suggested that low expression of p27kip1 may be useful as a marker of poor-prognosis synovial sarcoma.

UR - http://www.scopus.com/inward/record.url?scp=0035281785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035281785&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(20010301)91:5<1005::AID-CNCR1091>3.0.CO;2-O

DO - 10.1002/1097-0142(20010301)91:5<1005::AID-CNCR1091>3.0.CO;2-O

M3 - Article

C2 - 11251953

AN - SCOPUS:0035281785

VL - 91

SP - 1005

EP - 1012

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -